It is also necessary to amend the CN in order to take account of changes in requirements relating to statistics, to commercial policy and technological and commercial developments, by deleting obsolete codes, by introducing new subheadings to facilitate monitoring of specific goods; it is also necessary to adapt the list of international non-proprietary names (Annex 3 to Section II of Part Three (Tariff Annexes) of the CN) and the list of pharmaceutical intermediates, i.e. compounds of a kind used for the manufacture of finished pharmaceutical products (Annex 6 to Section II of Part Three (Tariff Annexes) of the CN), which are free of duty.
Recital 4, Regulation (EU) 2018/1602
In forcesince 11 Oct 2018